REFERENCES
- Morghal N E, Brocklebank J T, Meadow S R. A review of acute renal failure in children: incidence, etiology, and outcome. Clin Nephrol 1998; 49: 91–95, [CSA]
- Brivet F G, Kleinknecht D J, Loirat P, Landais P J. Acute renal failure in intensive care units—causes, outcome, and prognostic factors of hospital mortality: a prospective, multicenter study. French Study Group on acute renal failure. Crit Care Med. 1996; 24: 192–198, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Mills R M, Hobbs R E. How to use nesiritide in treating decompensated heart failure. Clev Clin J Med. 2002; 69: 252–256, [CSA]
- Publication committee for VMAC investigators. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. JAMA 2002; 287: 1531–1540, [CROSSREF]
- Cowie M R, Mendez G F. BNP and congestive heart failure. Prog Cardiovasc Dis. 2002; 44: 293–321, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Maack T. Receptors of atrial natriuretic factor. Annu Rev Physiol. 1992; 54: 11–27, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Abassi Z, Karram T, Ellaham S, et al. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance. Pharmacol Ther. 2004; 102: 223–241, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Packer M, Carver J R, Rodeheffer R J, et al. Effect of oral milrinone on mortality in severe chronic heart failure: the PROMISE study research group. New Engl J Med. 1991; 325: 1468–1475, [PUBMED], [INFOTRIEVE], [CSA]
- Silver M A, Horton D P, et al. Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failure. J Am Coll Cardiol. 2002; 39: 798–803, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Burger A J, Horton D P, LeJemtel T, et al. Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study. Am Heart J. 2002; 144: 1102–1108, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Abraham W T, Lowes B D, Ferguson D A, et al. Systemic hemodynamic, neurohormonal, and renal effect of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure. J Card Fail 1998; 4: 37–44, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Abraham W T, Adams K F, Fonarow G C, et al. Comparison of in-hospital mortality in patients treated with nesiritide vs. other parenteral vasoactive medications for acutely decompensated heart failure: and analysis from a large prospective registry database. J Card Fail 2003; 9: S81, [CROSSREF]
- DiDomenico R J, Park H Y, Southworth M R, et al. Guidelines for acute decompensated heart failure treatment. Ann Pharmacother 2004; 38: 649–660, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Francis G S, Siegel R M, Goldsmith S R, et al. Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Ann Intern Med. 1985; 103: 1–6, [PUBMED], [INFOTRIEVE]
- Gottlieb S S, Brater D C, Thomas I, et al. BG9719 (CVT-124) an A1 adenosine receptor antagonist protects against the decline in renal function observed with diuretic therapy. Circulation 2002; 105: 1348–1353, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Cotter G, Metzkor E, Kaluski E, et al. Randomized trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary edema. Lancet 1998; 351: 389–393, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Lombardi R, Ferreiro A, Servetto C. Renal function after cardiac surgery: adverse effect of furosemide. Ren Fail. 2003; 25: 775–786, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Bobadilla R V, Oppelt T F, Hirshy T C. Nesiritide treatment of noncardiogenic pulmonary edema. Ann Pharmacother 2003; 37: 530–533, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Sehra R, Underwood K R. Nesiritide improves urine output in severely ill pediatric patients awaiting heart transplantation without severe hypotension. J Card Fail 2003; 9: S70, [CROSSREF]
- Marshall J, Berkenbosch J W, Russo P, et al. Preliminary experience with nesiritide in the pediatric population. J Intensive Care Med. 2004; 19: 164–170, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Simsic J M, Reddy V S, Kanter K R, et al. Use of nesiritide (human b-type natriuretic peptide) in infants following cardiac surgery. Pediatr Cardiol., 2004 Jun 4 epub ahead of print
- Smith T, Rosen D A, Russo P, et al. Nesiritide during extracorporeal membrane oxygenation. Paediatr Anaesth
- Simsic J M, Scheurer M, Tobias J D, et al. Perioperative effects and safety of nesiritide following cardiac surgery in children. Pediatr Cardiol, (submitted)